Dimethyldioxolone

Taizhou Tianrui Pharmaceutical Co., Ltd. manufactures active pharmaceutical ingredients and intermediates for the cardiovascular and anti-infective segments, including olmesartan medoxomil and its triphenylmethyl-protected intermediate, candesartan cilexetil, valsartan, and rifaximin. The company currently sells primarily into the Asian market.